Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Amortizatization of Intangibles: 2020-2024

Historic Amortizatization of Intangibles for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $3.4 million.

  • Journey Medical's Amortizatization of Intangibles rose 30.71% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 28.15%. This contributed to the annual value of $3.4 million for FY2024, which is 9.11% down from last year.
  • Journey Medical's Amortizatization of Intangibles amounted to $3.4 million in FY2024, which was down 9.11% from $3.8 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Amortizatization of Intangibles ranged from a high of $4.3 million in FY2022 and a low of $1.4 million during FY2020.
  • In the last 3 years, Journey Medical's Amortizatization of Intangibles had a median value of $3.8 million in 2023 and averaged $3.8 million.
  • As far as peak fluctuations go, Journey Medical's Amortizatization of Intangibles soared by 81.13% in 2021, and later dropped by 11.92% in 2023.
  • Journey Medical's Amortizatization of Intangibles (Yearly) stood at $1.4 million in 2020, then soared by 81.13% to $2.6 million in 2021, then spiked by 66.29% to $4.3 million in 2022, then fell by 11.92% to $3.8 million in 2023, then decreased by 9.11% to $3.4 million in 2024.